William Darko

478 total citations
38 papers, 311 citations indexed

About

William Darko is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, William Darko has authored 38 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in William Darko's work include Antimicrobial Resistance in Staphylococcus (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). William Darko is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). William Darko collaborates with scholars based in United States and Germany. William Darko's co-authors include Robert W. Seabury, Christopher D. Miller, Adrienne Smith, Roy Guharoy, David F. Lehmann, Jeffrey M. Steele, Joseph J. Medicis, Christopher Miller, Wesley D. Kufel and John Noviasky and has published in prestigious journals such as CHEST Journal, Critical Care Medicine and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

William Darko

33 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Darko United States 10 96 86 78 64 63 38 311
Robert W. Seabury United States 11 144 1.5× 142 1.7× 65 0.8× 81 1.3× 102 1.6× 50 367
Darrel W. Hughes United States 13 68 0.7× 132 1.5× 39 0.5× 118 1.8× 56 0.9× 16 374
Melanie Smith United States 10 177 1.8× 201 2.3× 93 1.2× 199 3.1× 62 1.0× 33 543
Andrew C. Faust United States 11 66 0.7× 102 1.2× 54 0.7× 108 1.7× 51 0.8× 33 398
Rodolfo Sbrojavacca Italy 12 72 0.8× 57 0.7× 82 1.1× 80 1.3× 17 0.3× 24 386
Mir Mohammad Miri Iran 12 43 0.4× 123 1.4× 32 0.4× 74 1.2× 26 0.4× 53 403
Jennifer D. Twilla United States 12 25 0.3× 100 1.2× 66 0.8× 96 1.5× 54 0.9× 33 386
William Peppard United States 15 65 0.7× 145 1.7× 51 0.7× 177 2.8× 42 0.7× 54 646
Heather A. Personett United States 11 77 0.8× 104 1.2× 37 0.5× 155 2.4× 10 0.2× 24 391
Miriam Elman United States 12 30 0.3× 23 0.3× 153 2.0× 148 2.3× 38 0.6× 48 501

Countries citing papers authored by William Darko

Since Specialization
Citations

This map shows the geographic impact of William Darko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Darko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Darko more than expected).

Fields of papers citing papers by William Darko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Darko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Darko. The network helps show where William Darko may publish in the future.

Co-authorship network of co-authors of William Darko

This figure shows the co-authorship network connecting the top 25 collaborators of William Darko. A scholar is included among the top collaborators of William Darko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Darko. William Darko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Christopher D., et al.. (2025). Retrospective analysis of low-dose versus higher-dose haloperidol in older emergency department patients. The American Journal of Emergency Medicine. 92. 37–42.
2.
3.
Seabury, Robert W., et al.. (2023). Preparation/administration of push-dose versus continuous infusion epinephrine and phenylephrine: A simulation. The American Journal of Emergency Medicine. 74. 135–139.
4.
5.
6.
Seabury, Robert W., et al.. (2022). Does a Positive Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screen Predict the Risk for MRSA Skin and Soft Tissue Infection?. Annals of Pharmacotherapy. 57(6). 669–676. 3 indexed citations
7.
Seabury, Robert W., Stephanie Zyck, Christopher D. Miller, et al.. (2022). Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis. The American Journal of Emergency Medicine. 55. 16–19. 22 indexed citations
8.
Darko, William, Robert W. Seabury, Christopher D. Miller, et al.. (2021). Implementation of a formal pharmacy residency research certificate program. American Journal of Health-System Pharmacy. 78(5). 436–446. 8 indexed citations
9.
10.
Fazili, Tasaduq, Dongliang Wang, Jeffrey M. Steele, et al.. (2020). Nephrotoxicity Risk and Clinical Effectiveness of Continuous versus Intermittent Infusion Vancomycin Among Patients in an Outpatient Parenteral Antimicrobial Therapy Program. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(4). 357–362. 15 indexed citations
11.
12.
Seabury, Robert W., William Darko, Christopher D. Miller, Jeffrey M. Steele, & Wesley D. Kufel. (2019). Publications for Pharmacy Residents Are Challenging but Not “Nearly Unattainable”. Hospital Pharmacy. 55(3). 153–153. 2 indexed citations
13.
Zyck, Stephanie, Christopher D. Miller, Satish Krishnamurthy, et al.. (2019). Retrospective Assessment of Desmopressin Effectiveness and Safety in Patients With Antiplatelet-Associated Intracranial Hemorrhage*. Critical Care Medicine. 47(12). 1759–1765. 28 indexed citations
14.
Kufel, Wesley D., et al.. (2017). Clinical Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We Getting it Right?. Hospital Pharmacy. 52(3). 214–220. 10 indexed citations
15.
Kufel, Wesley D., et al.. (2017). Impact of premix antimicrobial preparation and time to administration in septic patients. Canadian Journal of Emergency Medicine. 20(4). 565–571. 3 indexed citations
16.
Darko, William, et al.. (2016). Pharmacy impact on medication reconciliation in the medical intensive care unit. Journal of Research in Pharmacy Practice. 5(2). 142–142. 11 indexed citations
17.
Seabury, Robert W., et al.. (2016). Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?. Journal of Pharmacy Practice. 30(3). 329–335. 44 indexed citations
18.
Darko, William, et al.. (2016). A Rare Case of Propofol-Induced Myoclonus After Prolonged Infusion. CHEST Journal. 150(4). 449A–449A.
19.
Noviasky, John, et al.. (2003). Science or Fiction: Use of Nesiritide as a First‐Line Agent?. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(8). 1081–1083. 10 indexed citations
20.
Darko, William, Joseph J. Medicis, Adrienne Smith, Roy Guharoy, & David F. Lehmann. (2003). Mississippi Mud No More: Cost‐Effectiveness of Pharmacokinetic Dosage Adjustment of Vancomycin to Prevent Nephrotoxicity. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(5). 643–650. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert W. Seabury Breakdown of academic impact, for papers by Darrel W. Hughes Breakdown of academic impact, for papers by Melanie Smith Breakdown of academic impact, for papers by Andrew C. Faust Breakdown of academic impact, for papers by Rodolfo Sbrojavacca Breakdown of academic impact, for papers by Mir Mohammad Miri Breakdown of academic impact, for papers by Jennifer D. Twilla Breakdown of academic impact, for papers by William Peppard Breakdown of academic impact, for papers by Heather A. Personett Breakdown of academic impact, for papers by Miriam Elman
Rankless by CCL
2026